Granahan Investment Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-76,298
Closed -$29.8K 199
2023
Q4
$29.8K Sell
76,298
-245,175
-76% -$196K ﹤0.01% 180
2023
Q3
$514K Buy
321,473
+302,726
+1,615% +$836K 0.02% 176
2023
Q2
$54.7K Buy
18,747
+7,677
+69% +$17.4K ﹤0.01% 175
2023
Q1
$26.8K Buy
+11,070
New +$30.7K ﹤0.01% 165
2022
Q3
Sell
-324,199
Closed -$794K 181
2022
Q2
$794K Sell
324,199
-6,080
-2% -$28.9K 0.03% 166
2022
Q1
$2.29M Sell
330,279
-190,969
-37% -$2.02M 0.06% 167
2021
Q4
$8.29M Buy
521,248
+23,318
+5% +$467K 0.17% 124
2021
Q3
$9.98M Buy
+497,930
New +$12.8M 0.19% 114

Other funds holding RNLX

Granahan Investment Management's RNLX Position: Q1 2024 in Review

Granahan Investment Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2024, closing a stake of 76,298 shares — an estimated $29.8K sold.

Granahan Investment Management first reported a position in RNLX in Q3 2021 and held it in 8 quarters. The position peaked at $9.98M in Q3 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q1 2024.

  • Granahan Investment Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Granahan Investment Management sold 76,298 Renalytix plc American Depositary Shares shares in Q1 2024, an estimated $29.8K.
  • Granahan Investment Management first reported a position in Renalytix plc American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • Granahan Investment Management's Renalytix plc American Depositary Shares position peaked at $9.98M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2024.

Based on Granahan Investment Management's 13F filing for Q1 2024, filed 15 May 2024.